Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Ранг среди акций #6138
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Цена акции
$154.04
Рыночная капитализация
$2.21B
Изменение (1 день)
-0.19%
Изменение (1 год)
172.88%
Страна
US
Торговля Palvella Therapeutics, Inc. (PVLA)

Категория

История цены акций Palvella Therapeutics, Inc. (PVLA)
Наивысшая цена закрытия: $151.69 2026-08-01

Наименьшая цена закрытия: $13.11 2024-12-01
История цены акций Palvella Therapeutics, Inc. с 2024 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 7.48%
2025 649.84%
2024 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$547.65 40.75%
US
$1.06K 49.04%
NL
$122.63 -12.65%
AU
$143.63 472.23%
US
$765.25 7.19%
CH